Skip to Content
Global News Select

Edwards Lifesciences Longtime Chair To Retire

By Ben Glickman


Edwards Lifesciences said Tuesday that chair Michael Mussallem planned to retire about a year after stepping down as chief executive.

The Irvine, Calif.-based company said in a regulatory filing that Mussallem, who served as CEO of Edwards from 2000 to 2023, is expected to be succeeded as chair by Nicholas Valeriani, an independent director.

Mussallem retired as CEO at the 2023 annual meeting, transitioning into the non-executive chair role. He was succeeded in the CEO role by Bernard Zovighian.

The company's annual meeting is scheduled for May 7.

Edwards said in the filing that board member Martha Marsh had reached the retirement age outlined in the company's governance guidelines.


Write to Ben Glickman at

(END) Dow Jones Newswires

March 26, 2024 16:42 ET (20:42 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Market Updates

Sponsor Center